Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Scalp Psoriasis
Interventions
DRUG

Dimethicone

The treatment will be carried out once daily (in the evening) onto all scaling areas of the scalp over a period of 2 weeks, with the last application of investigational products being applied one day prior to the final visit.

DRUG

Salicylic Acid

The treatment will be carried out once daily (in the evening) onto all scaling areas of the scalp over a period of 2 weeks, with the last application of investigational products being applied one day prior to the final visit.

Trial Locations (1)

20246

University Medical Center Hamburg-Eppendorf (UKE), Hamburg

All Listed Sponsors
collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

lead

G. Pohl-Boskamp GmbH & Co. KG

INDUSTRY

NCT01914627 - Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis | Biotech Hunter | Biotech Hunter